Increased solubility flavanolignan preparations

Details for Australian Patent Application No. 2002323517 (hide)

Owner IVAX PHARMACEUTICALS s.r.o.

Inventors Stuchlik, Milan; Cvak, Ladislav; Benesova, Kvetoslava

Agent Griffith Hack

Pub. Number AU-B-2002323517

PCT Number PCT/US02/27713

PCT Pub. Number WO2003/020291

Priority PV 2001-3153 30.08.01 CZ

Filing date 30 August 2002

Wipo publication date 18 March 2003

Acceptance publication date 10 December 2009

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 31/79 (2006.01)

A61K 36/00 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 36/28 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 35/00 (2006.01) Antineoplastic agents

A61P 39/02 (2006.01) General protective or antinoxious agents

C07D 311/40 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): PV 2001-3153 30.08.01 CZ

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002323517

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

31 August 2006 Section 223 Application Received

  IVAX CORPORATION An application to extend the time from 30 Mar 2004 to 30 May 2006 in which to enter the National Phase has been filed . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2004

16 November 2006 Section 223 Application Allowed

  IVAX CORPORATION The time in which to enter the National Phase has been extended to 30 May 2006. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2003

18 January 2007 Assignment Registered

  IVAX C.R., a.s. The patent has been assigned to IVAX PHARMACEUTICALS s.r.o.

10 December 2009 Application Accepted

  Published as AU-B-2002323517

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002323518-DEVICE AND METHODS FOR INSPECTING SOLDERED CONNECTIONS

2002323516-GASOLINE FUEL ADDITIZED WITH FRICTION MODIFIER AND NONMETALLIC AND NON-OVERBASED DETERGENT FOR ENHANCED ENGINE PERFORMANCE